Plexus (NASDAQ:PLXS) Releases Q4 Earnings Guidance

Plexus (NASDAQ:PLXS) issued an update on its fourth quarter earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $1.50-1.65 for the period, compared to the consensus estimate of $1.36. The company issued revenue guidance of $0.99-1.03 billion, compared to the consensus revenue estimate of $1.02 billion. Plexus also updated its Q4 2024 guidance to 1.500-1.650 EPS.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on PLXS. Needham & Company LLC raised their price objective on Plexus from $114.00 to $144.00 and gave the company a buy rating in a research report on Friday. Stifel Nicolaus raised their price objective on Plexus from $90.00 to $95.00 and gave the company a hold rating in a research report on Friday, April 26th. Finally, Benchmark raised their price objective on Plexus from $110.00 to $120.00 and gave the company a buy rating in a research report on Friday, June 21st. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, Plexus currently has a consensus rating of Hold and a consensus target price of $117.75.

Plexus Trading Down 0.5 %

Shares of NASDAQ:PLXS traded down $0.62 during trading on Friday, reaching $128.97. The company’s stock had a trading volume of 55,078 shares, compared to its average volume of 125,576. The company has a current ratio of 1.51, a quick ratio of 0.64 and a debt-to-equity ratio of 0.15. Plexus has a 12 month low of $87.21 and a 12 month high of $132.46. The firm’s 50 day simple moving average is $108.33 and its two-hundred day simple moving average is $101.10. The stock has a market capitalization of $3.53 billion, a PE ratio of 36.06 and a beta of 0.90.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, July 24th. The technology company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.17. Plexus had a net margin of 2.82% and a return on equity of 9.68%. The firm had revenue of $960.70 million during the quarter, compared to the consensus estimate of $981.32 million. During the same quarter last year, the firm earned $1.32 EPS. The firm’s revenue for the quarter was down 6.0% compared to the same quarter last year. On average, research analysts predict that Plexus will post 3.67 EPS for the current fiscal year.

Insider Activity at Plexus

In other Plexus news, CEO Todd P. Kelsey sold 1,000 shares of the firm’s stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $102.10, for a total value of $102,100.00. Following the completion of the sale, the chief executive officer now owns 113,810 shares of the company’s stock, valued at $11,620,001. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, CEO Todd P. Kelsey sold 1,656 shares of Plexus stock in a transaction that occurred on Tuesday, July 16th. The shares were sold at an average price of $115.00, for a total transaction of $190,440.00. Following the completion of the sale, the chief executive officer now owns 96,682 shares of the company’s stock, valued at $11,118,430. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Todd P. Kelsey sold 1,000 shares of Plexus stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $102.10, for a total transaction of $102,100.00. Following the transaction, the chief executive officer now directly owns 113,810 shares in the company, valued at $11,620,001. The disclosure for this sale can be found here. In the last quarter, insiders sold 35,386 shares of company stock valued at $3,749,884. Insiders own 2.39% of the company’s stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.